Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
An ever-growing amount of diagnostic data has led to information overload, often making accurate diagnoses more difficult.
The platform offers a flexible modular hematology solution that is fully scalable with myriad configurations for mid to large-scale labs.
The Prospective Risk Adjustment solution delivers timely, evidence-based AI-powered insights that directly impact member outcomes.
Read MoreChris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today.
Read MoreThe FDA cleared Trinity Biotech’s Premier Resolution System automated analyzer for the precise quantification of hemoglobins F and A2.
Read MoreA team of researchers assessed whether a fully automated system utilizing AI can accurately diagnose malaria.
Read MoreBrooks Automation will feature newly expanded automation capabilities at the upcoming 2023 AACC Clinical Lab Expo.
Read MoreArtificial Intelligence is often depicted as a godsend or a nightmare, but the right perspective will keep it a useful tool.
Read MoreDiagnostica Stago Inc. announced 510(k) clearance of the Max Generation3 family of analyzers including STA R Max3and STA Compact Max3.
Read MoreRevvity’s EuroImmun business has launched the UNIQO 160 automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics.
Read MoreOmicsveu has introduced a staining automation system for multiplex proteomics designed to meet Hyperion multiplex IHC protocols.
Read MoreClear Dx Microbial Surveillance WGS is a fully automated, end-to-end whole genome sequencing solution for bacterial and fungal isolates.
Read MoreDigital Diagnostics, an artificial intelligence diagnostic health care company, has expanded into lab settings in the Southeastern U.S.
Read MoreLIMS/LIS automation will ensure a lab’s competitiveness and long-term sustainability in today’s evolving health care market.
Read MoreINTEGRA Biosciences acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for NGS protocols.
Read MoreAutomated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.
Read MoreA co-marketing agreement with Biosero and Analytik Jena will allow them to promote applications of their combined laboratory automation tech.
Read More